Management of post-acute covid-19 in primary care
By Trisha Greenhalgh, M. Knight, C. A'Court, M. Buxton, L. Husain. British medical journal, 2020
1,483 citations recorded by the source corpus.
### What you need to know Post-acute covid-19 (“long covid”) seems to be a multisystem disease, sometimes occurring after a relatively mild acute illness.1 Clinical management requires a whole-patient perspective.2 This article, intended for primary care clinicians, relates to the patient who has a delayed recovery from an episode of covid-19 that was managed in the community or in a standard hospital ward. Broadly, such patients can be divided into those who may have serious sequelae (such as thromboembolic complications) and those with a non-specific clinical picture, often dominated by fatigue and breathlessness. The specialist rehabilitation needs of a third group, covid-19 patients whose acute illness required intensive care, have been covered elsewhere.3 In the absence of agreed definitions, for the purposes of this article we define post-acute covid-19 as extending beyond three weeks from the onset of first symptoms and chronic covid-19 as extending beyond 12 weeks. Since many people were not tested, and false negative tests are common,4 we suggest that a positive test for covid-19 is not a prerequisite for diagnosis. ### How common is it? Around 10% of patients who have tested positive for SARS-CoV-2 virus remain unwell beyond three weeks, and a smaller proportion for months (see box 1).7 This is based on the UK COVID Symptom Study, in which people enter their ongoing symptoms on a smartphone app. This percentage is lower than that cited in many published observational …
Subfields: Clinical Psychology, Infectious Diseases, Neurology
View Paper: https://www.semanticscholar.org/paper/89ece7bdf9bbd01ebbd5070bfc04b9e83fbd6955
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
In Neurology
Citations in the corpus
- Characterizing long COVID in an international cohort: 7 months of symptoms and their impact (2020, background): “While respiratory and some cardiovascular symptoms have been widely reported, neurological symptoms remain unclear [33].”
- Symptoms, complications and management of long COVID: a review (2021, background): “It is therefore essential that these are adequately managed in order to avoid clinical deterioration and the need for readmission in these patients.(81)”
- More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis (2021, neutral): “Health Care related Mental Health 1 28 404 7 (5-10)”
- Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 (2021, background): “In the meantime, clinical services need to be prepared and resourced to enable management of long-COVID features according to the best available evidence as it emerges [7,30,31].”
- Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments (2021, background): “However, para-cetamol and non-steroidal anti-inflammatory drugs may be used to manage specific symptoms such as fever [16].”
- Characterising long COVID: a living systematic review (2021, background): “In several symptoms and signs, the heterogeneity of the results was found to be associated with level of hospitalisation, hospital settings, location of the studies and follow-up timing using subgroup analysis (online supplemental files 5-8).”